Schindler, H., Lusky, F., Daniello, L., Elshiaty, M., Gaißmaier, L., Gente, K., . . . Christopoulos, P. (2022). Serum cytokines predict efficacy and toxicity, but are not useful for disease monitoring in lung cancer treated with PD-(L)1 inhibitors. Frontiers in oncology, 12, . https://doi.org/10.3389/fonc.2022.1010660
Chicago-Zitierstil (17. Ausg.)Schindler, Hannah, et al. "Serum Cytokines Predict Efficacy and Toxicity, but Are Not Useful for Disease Monitoring in Lung Cancer Treated with PD-(L)1 Inhibitors." Frontiers in Oncology 12 (2022). https://doi.org/10.3389/fonc.2022.1010660.
MLA-Zitierstil (9. Ausg.)Schindler, Hannah, et al. "Serum Cytokines Predict Efficacy and Toxicity, but Are Not Useful for Disease Monitoring in Lung Cancer Treated with PD-(L)1 Inhibitors." Frontiers in Oncology, vol. 12, 2022, https://doi.org/10.3389/fonc.2022.1010660.